Bowman Birk inhibitor concentrate and oral leukoplakia: A randomized phase IIb trial.
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2013
At a glance
- Drugs Bowman-Birk inhibitor concentrate (Primary)
- Indications Orofacial cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 23 Oct 2006 New trial record.